This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Astellas Pharma Europe 2009 Awards
All three Novartis A(H1N1) 2009 influenza vaccines prequalified by WHO
NICE approves PharmaMar cancer drug
Protein find raises swine flu hopes
Merck buys UK biotech drug maker
Boehringer Ingelheim initiates first phase III clinical trial in ovarian cancer
NICE unable to recommend pemetrexed
FDA panel rejects OSI cancer drug
Hormone cuts chance of Alzheimer’s
Alzheimer’s drug trials curbed
Advisers recommend drug use widened
Newham University Hospital uses Cerner experience centre to gain additional value from Cerner millennium solutions
« Previous
1
…
92
93
94
95
96
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: